Immunohistopathogenesis of persistent generalized lymphadenopathy in HIV-positive patients.
Baroni CD, Vitolo D, Uccini S.
Ric Clin Lab. 1990 Jan-Mar;20(1):1-10. doi: 10.1007/BF02910143.
Epstein-Barr virus and its association with disease - a review of relevance to general practice.
Fugl A, Andersen CL.
BMC Fam Pract. 2019 May 14;20(1):62. doi: 10.1186/s12875-019-0954-3.
The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy.
Schechter MT, Boyko WJ, Jeffries E, Willoughby B, Nitz R, Constance P.
Can Med Assoc J. 1985 Jun 1;132(11):1273-9.
Clinical manifestations of HIV infection, including persistent generalized lymphadenopathy and AIDS-related complex.
Abrams DI.
J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1217-22. doi: 10.1016/0190-9622(90)70166-f.
Persistent generalized lymphadenopathy in homosexual men: clinical, pathological and immunologic characteristics.
Gilmore NJ, Prchal JF, Jothy S.
Can Med Assoc J. 1983 Nov 1;129(9):960-5.
AIDS-related lymphadenopathies.
Said JW.
Semin Diagn Pathol. 1988 Nov;5(4):365-75.
Canakinumab (Ilaris) [Internet].
[No authors listed]
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.
Persistent, generalized lymphadenopathy among homosexual males.
Centers for Disease Control (CDC).
MMWR Morb Mortal Wkly Rep. 1982 May 21;31(19):249-51.
Persistent generalized lymphadenopathy and non-Hodgkin's lymphoma in AIDS: association with Rochalimaea henselae infection.
Peter JB, Boyle M, Patnaik M, Hadfield TL, Barka NE, Schwartzman WA, Penny RS.
Clin Diagn Lab Immunol. 1994 Jan;1(1):115-6. doi: 10.1128/cdli.1.1.115-116.1994.
Lymph nodes in HIV-positive drug abusers with persistent generalized lymphadenopathy: histology, immunohistochemistry, and pathogenetic correlations.
Baroni CD, Uccini S.
Prog AIDS Pathol. 1990;2:33-50.
